American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evolving treatment patterns in chronic lymphocytic leukemia among experts and community practitioners: Analysis of an online decision support tool
    Meeting Abstract

    Topping, R. P.; Rosenthal, K.; Awan, F. T.; Brown, J. R.; Lamanna, N.; Sharman, J. P.; Quill, T. A.; Zelenetz, A. D.
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical experience of tabelecleucel in patients with life-threatening complications of Epstein-Barr virus viremia
    Meeting Abstract

    Torno, L.; Dahlberg, A.; Ghobadi, A.; Stiff, P.; Reshef, R.; Weng, W. K.; Navarro, W.; Gamelin, L.; Dinavahi, R.; Sun, Y.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • NOTCH and CAR signaling control T cell lineage commitment from pluripotent stem cells
    Meeting Abstract

    Van der Stegen, S.; Lindenbergh, P.; Petrovic, R.; Whitlock, B.; Clarke, R.; Valamehr, B.; Riviere, I.; Sadelain, M.
    Blood (2020)

    Fulltext@MSK | Save
  • High dimensional tissue-based spatial analysis of the tumor microenvironment of follicular lymphoma reveals unique immune niches inside malignant follicles
    Meeting Abstract

    Villasboas, J. C.; Mondello, P.; Fama, A.; Larson, M. C.; Feldman, A. L.; Yang, Z. Z.; Galkin, I.; Svekolkin, V.; Postovalova, E.; Bagaev, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Venetoclax re-treatment of chronic lymphocytic leukemia (CLL) patients after a previous venetoclax-based regimen
    Meeting Abstract

    Thompson, M. C.; Allan, J. N.; Sail, K.; Manzoor, B. S.; Pu, J. J.; Barr, P. M.; Coombs, C. C.; Schuster, S. J.; Skarbnik, A.; Rhodes, J. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Phase 1 and dose expansion study of APR-246 in combination with ibrutinib or venetoclax-based therapy in subjects with TP53-mutant relapsed and/or refractory non-hodgkin lymphomas (NHL) including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)
    Meeting Abstract

    Thompson, M. C.; Davids, M. S.; Jain, N.; Soumerai, J. D.; Geethakumari, P. R.; Gubits, A.; Hickman, D.; Wennborg, A.; Attar, E. C.; Abdel-Wahab, O.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Male-biased spliceosome mutations in blastic plasmacytoid dendritic cell neoplasm (BPDCN) impair pDC activation and apoptosis
    Meeting Abstract

    Togami, K.; Chung, S. S.; Madan, V.; Kenyon, C. M.; Cabal-Hierro, L.; Taylor, J.; Kim, S.; Griffin, G. K.; Ghandi, M.; Li, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • VRd versus KRd safety profiles in newly diagnosed multiple myeloma patients using real-world evidence data from a single institution: VRd has high rates of chronic neuropathy, and KRd has low rates of cardiopulmonary or renal toxicities when using optimized IV fluid management coupled with baseline cardiac workup
    Meeting Abstract

    Tan, C.; Diamond, B.; Hultcrantz, M.; Korde, N.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Shah, U. A.; Lu, S. X.; Patel, D.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical benefit and tolerability of crenolanib in children with relapsed acute myeloid leukemia harboring treatment resistant FLT3 ITD and variant FLT3 TKD mutations treated on compassionate access
    Meeting Abstract

    Tarlock, K.; Meshinchi, S.; Rubnitz, J. E.; Karol, S. E.; Spitzer, B.; Sabnis, A. J.; Pathan, A.; Messahel, B.
    Blood (2020)

    Fulltext@MSK | Save
  • Cranial radiation can be eliminated in most children with T-cell acute lymphoblastic leukemia (T-ALL) and bortezomib potentially improves survival in children with T-cell lymphoblastic lymphoma (T-LL): Results of Children's Oncology Group (COG) trial AALL1231
    Meeting Abstract

    Teachey, D. T.; Devidas, M.; Wood, B. L.; Chen, Z.; Hayashi, R. J.; Annett, R. D.; Asselin, B. L.; August, K. J.; Cho, S. Y.; Dunsmore, K. P.; more...
    Blood (2020)

    Fulltext@MSK | Save